$5.08
-0.14-2.68%
In chiusura: Nov 20, 4:00 PM EST
$5.29
0.214.13%
Post-mercato: Nov 20, 9:28 AM EST

AN2 Therapeutics (ANTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $-0.17 | $-0.20 | 15.0 % |
| Q2 | Aug 11, 2026 | $-0.18 | $-0.24 | 25.0 % |
| Q1 | May 11, 2026 | $-0.29 | $-0.23 | -26.1 % |
| Q4 | Mar 17, 2026 | $-0.29 | $-0.24 | -20.8 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.24 | $-0.23 | $-0.24 |
| Actual | $-0.17 | $-0.18 | $-0.29 | $-0.29 |
| Surprise | +15.0% | +25.0% | -26.1% | -20.8% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.20 | $-0.19 |
| Revenue | ||
| Consensus | — | — |